Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ISPC vs BRLT vs SIG vs MEDP vs ICLR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ISPC
iSpecimen Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$711K
5Y Perf.-99.9%
BRLT
Brilliant Earth Group, Inc.

Luxury Goods

Consumer CyclicalNASDAQ • US
Market Cap$226M
5Y Perf.-89.3%
SIG
Signet Jewelers Limited

Luxury Goods

Consumer CyclicalNYSE • BM
Market Cap$3.53B
5Y Perf.+10.6%
MEDP
Medpace Holdings, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$12.11B
5Y Perf.+124.0%
ICLR
ICON Public Limited Company

Medical - Diagnostics & Research

HealthcareNASDAQ • IE
Market Cap$9.51B
5Y Perf.-52.5%

ISPC vs BRLT vs SIG vs MEDP vs ICLR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ISPC logoISPC
BRLT logoBRLT
SIG logoSIG
MEDP logoMEDP
ICLR logoICLR
IndustryMedical - Diagnostics & ResearchLuxury GoodsLuxury GoodsMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Market Cap$711K$226M$3.53B$12.11B$9.51B
Revenue (TTM)$2M$443M$0.00$2.68B$8.10B
Net Income (TTM)$-10M$-12M$0.00$460M$599M
Gross Margin1.2%56.5%29.1%26.9%
Operating Margin-465.4%-2.4%21.0%12.2%
Forward P/E47.7x9.2x25.0x10.7x
Total Debt$269K$38M$0.00$250M$3.60B
Cash & Equiv.$7M$79M$497M$539M

ISPC vs BRLT vs SIG vs MEDP vs ICLRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ISPC
BRLT
SIG
MEDP
ICLR
StockSep 21May 26Return
iSpecimen Inc. (ISPC)1000.1-99.9%
Brilliant Earth Gro… (BRLT)10010.7-89.3%
Signet Jewelers Lim… (SIG)100110.6+10.6%
Medpace Holdings, I… (MEDP)100224.0+124.0%
ICON Public Limited… (ICLR)10047.5-52.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: ISPC vs BRLT vs SIG vs MEDP vs ICLR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MEDP leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Brilliant Earth Group, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. SIG also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ISPC
iSpecimen Inc.
The Healthcare Pick

ISPC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
BRLT
Brilliant Earth Group, Inc.
The Income Pick

BRLT is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 0 yrs, beta 1.14, yield 1.8%
  • Lower volatility, beta 1.14, Low D/E 47.8%, current ratio 1.61x
  • Beta 1.14, yield 1.8%, current ratio 1.61x
  • Beta 1.14 vs SIG's 1.77
Best for: income & stability and sleep-well-at-night
SIG
Signet Jewelers Limited
The Value Play

SIG ranks third and is worth considering specifically for value.

  • Lower P/E (9.2x vs 47.7x)
Best for: value
MEDP
Medpace Holdings, Inc.
The Growth Play

MEDP carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 20.0%, EPS growth 21.0%, 3Y rev CAGR 20.1%
  • 14.3% 10Y total return vs ICLR's 90.2%
  • PEG 0.78 vs ICLR's 1.53
  • 20.0% revenue growth vs SIG's -100.0%
Best for: growth exposure and long-term compounding
ICLR
ICON Public Limited Company
The Value Angle

Among these 5 stocks, ICLR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMEDP logoMEDP20.0% revenue growth vs SIG's -100.0%
ValueSIG logoSIGLower P/E (9.2x vs 47.7x)
Quality / MarginsMEDP logoMEDP17.2% margin vs ISPC's -5.4%
Stability / SafetyBRLT logoBRLTBeta 1.14 vs SIG's 1.77
DividendsBRLT logoBRLT1.8% yield; the other 4 pay no meaningful dividend
Momentum (1Y)MEDP logoMEDP+41.0% vs ISPC's -88.8%
Efficiency (ROA)MEDP logoMEDP24.8% ROA vs ISPC's -133.6%

ISPC vs BRLT vs SIG vs MEDP vs ICLR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ISPCiSpecimen Inc.
FY 2025
Product
89.9%$2M
Shipping and Handling
10.1%$193,998
BRLTBrilliant Earth Group, Inc.

Segment breakdown not available.

SIGSignet Jewelers Limited
FY 2026
Bridal
42.0%$2.9B
Fashion
38.6%$2.6B
Service
11.8%$804M
Watches
5.1%$350M
Other Product
2.4%$166M
MEDPMedpace Holdings, Inc.
FY 2025
Oncology
29.5%$748M
Metabolic
29.4%$745M
Other
16.1%$409M
Central Nervous System
10.1%$255M
Cardiology
9.5%$239M
Antiviral And Anti Infective
5.3%$135M
ICLRICON Public Limited Company
FY 2012
Clinical Research
92.2%$1.0B
Central Laboratory
7.8%$87M

ISPC vs BRLT vs SIG vs MEDP vs ICLR — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMEDPLAGGINGICLR

Income & Cash Flow (Last 12 Months)

MEDP leads this category, winning 4 of 6 comparable metrics.

ICLR and SIG operate at a comparable scale, with $8.1B and $0 in trailing revenue. MEDP is the more profitable business, keeping 17.2% of every revenue dollar as net income compared to ISPC's -5.4%. On growth, MEDP holds the edge at +26.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricISPC logoISPCiSpecimen Inc.BRLT logoBRLTBrilliant Earth G…SIG logoSIGSignet Jewelers L…MEDP logoMEDPMedpace Holdings,…ICLR logoICLRICON Public Limit…
RevenueTrailing 12 months$2M$443M$0$2.7B$8.1B
EBITDAEarnings before interest/tax-$7M-$6M$0$577M$1.4B
Net IncomeAfter-tax profit-$10M-$12M$0$460M$599M
Free Cash FlowCash after capex-$4M$14M-$2M$745M$996M
Gross MarginGross profit ÷ Revenue+1.2%+56.5%+29.1%+26.9%
Operating MarginEBIT ÷ Revenue-4.7%-2.4%+21.0%+12.2%
Net MarginNet income ÷ Revenue-5.4%-2.6%+17.2%+7.4%
FCF MarginFCF ÷ Revenue-2.2%+3.1%+27.8%+12.3%
Rev. Growth (YoY)Latest quarter vs prior year-96.5%+6.0%-2.9%+26.5%+0.6%
EPS Growth (YoY)Latest quarter vs prior year+93.1%-2.3%-146.7%+16.6%-98.7%
MEDP leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — ISPC and ICLR each lead in 2 of 7 comparable metrics.

At 13.1x trailing earnings, ICLR trades at a 53% valuation discount to MEDP's 27.7x P/E. Adjusting for growth (PEG ratio), MEDP offers better value at 0.87x vs ICLR's 1.86x — a lower PEG means you pay less per unit of expected earnings growth.

MetricISPC logoISPCiSpecimen Inc.BRLT logoBRLTBrilliant Earth G…SIG logoSIGSignet Jewelers L…MEDP logoMEDPMedpace Holdings,…ICLR logoICLRICON Public Limit…
Market CapShares × price$710,973$226M$3.5B$12.1B$9.5B
Enterprise ValueMkt cap + debt − cash-$6M$185M$3.5B$11.9B$12.6B
Trailing P/EPrice ÷ TTM EPS-0.06x-5.72x27.75x13.06x
Forward P/EPrice ÷ next-FY EPS est.47.67x9.22x24.96x10.73x
PEG RatioP/E ÷ EPS growth rate0.87x1.86x
EV / EBITDAEnterprise value multiple252.02x21.07x7.92x
Price / SalesMarket cap ÷ Revenue0.37x0.52x4.79x1.15x
Price / BookPrice ÷ Book value/share0.19x2.65x27.27x1.09x
Price / FCFMarket cap ÷ FCF39.31x17.76x8.50x
Evenly matched — ISPC and ICLR each lead in 2 of 7 comparable metrics.

Profitability & Efficiency

MEDP leads this category, winning 5 of 9 comparable metrics.

MEDP delivers a 120.9% return on equity — every $100 of shareholder capital generates $121 in annual profit, vs $-5 for ISPC. ISPC carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to MEDP's 0.55x. On the Piotroski fundamental quality scale (0–9), ICLR scores 7/9 vs SIG's 1/9, reflecting strong financial health.

MetricISPC logoISPCiSpecimen Inc.BRLT logoBRLTBrilliant Earth G…SIG logoSIGSignet Jewelers L…MEDP logoMEDPMedpace Holdings,…ICLR logoICLRICON Public Limit…
ROE (TTM)Return on equity-5.0%-14.0%+120.9%+6.3%
ROA (TTM)Return on assets-133.6%-5.5%+24.8%+3.6%
ROICReturn on invested capital-9.7%+154.9%+6.5%
ROCEReturn on capital employed-2.6%-3.4%+65.7%+7.8%
Piotroski ScoreFundamental quality 0–934167
Debt / EquityFinancial leverage0.09x0.48x0.55x0.38x
Net DebtTotal debt minus cash-$7M-$41M$0-$247M$3.1B
Cash & Equiv.Liquid assets$7M$79M$497M$539M
Total DebtShort + long-term debt$268,798$38M$0$250M$3.6B
Interest CoverageEBIT ÷ Interest expense-510.88x-0.92x3.96x
MEDP leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MEDP leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in MEDP five years ago would be worth $26,697 today (with dividends reinvested), compared to $9 for ISPC. Over the past 12 months, MEDP leads with a +41.0% total return vs ISPC's -88.8%. The 3-year compound annual growth rate (CAGR) favors MEDP at 26.5% vs ISPC's -84.1% — a key indicator of consistent wealth creation.

MetricISPC logoISPCiSpecimen Inc.BRLT logoBRLTBrilliant Earth G…SIG logoSIGSignet Jewelers L…MEDP logoMEDPMedpace Holdings,…ICLR logoICLRICON Public Limit…
YTD ReturnYear-to-date-55.2%-20.1%+2.2%-25.7%-34.0%
1-Year ReturnPast 12 months-88.8%+9.8%+36.9%+41.0%-10.1%
3-Year ReturnCumulative with dividends-99.6%-57.7%+29.0%+102.4%-34.4%
5-Year ReturnCumulative with dividends-99.9%-90.2%+47.4%+167.0%-44.8%
10-Year ReturnCumulative with dividends-99.9%-90.2%-9.5%+1425.7%+90.2%
CAGR (3Y)Annualised 3-year return-84.1%-24.9%+8.9%+26.5%-13.1%
MEDP leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BRLT and SIG each lead in 1 of 2 comparable metrics.

BRLT is the less volatile stock with a 1.14 beta — it tends to amplify market swings less than SIG's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SIG currently trades 79.2% from its 52-week high vs ISPC's 4.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricISPC logoISPCiSpecimen Inc.BRLT logoBRLTBrilliant Earth G…SIG logoSIGSignet Jewelers L…MEDP logoMEDPMedpace Holdings,…ICLR logoICLRICON Public Limit…
Beta (5Y)Sensitivity to S&P 5001.63x1.14x1.77x1.21x1.64x
52-Week HighHighest price in past year$127.20$3.10$110.20$628.92$211.00
52-Week LowLowest price in past year$0.36$1.21$61.92$284.48$66.57
% of 52W HighCurrent price vs 52-week peak+4.0%+46.1%+79.2%+67.4%+59.0%
RSI (14)Momentum oscillator 0–10045.551.249.441.462.8
Avg Volume (50D)Average daily shares traded1.1M57K912K371K1.1M
Evenly matched — BRLT and SIG each lead in 1 of 2 comparable metrics.

Analyst Outlook

SIG leads this category, winning 1 of 1 comparable metric.

Analyst consensus: BRLT as "Hold", SIG as "Hold", MEDP as "Hold", ICLR as "Buy". Consensus price targets imply 26.0% upside for SIG (target: $110) vs 17.5% for BRLT (target: $2). BRLT is the only dividend payer here at 1.80% yield — a key consideration for income-focused portfolios.

MetricISPC logoISPCiSpecimen Inc.BRLT logoBRLTBrilliant Earth G…SIG logoSIGSignet Jewelers L…MEDP logoMEDPMedpace Holdings,…ICLR logoICLRICON Public Limit…
Analyst RatingConsensus buy/hold/sellHoldHoldHoldBuy
Price TargetConsensus 12-month target$1.68$110.00$498.86$152.13
# AnalystsCovering analysts11301930
Dividend YieldAnnual dividend ÷ price+1.8%
Dividend StreakConsecutive years of raises03
Dividend / ShareAnnual DPS$0.03
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.2%0.0%+7.6%+5.3%
SIG leads this category, winning 1 of 1 comparable metric.
Key Takeaway

MEDP leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SIG leads in 1 (Analyst Outlook). 2 tied.

Best OverallMedpace Holdings, Inc. (MEDP)Leads 3 of 6 categories
Loading custom metrics...

ISPC vs BRLT vs SIG vs MEDP vs ICLR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ISPC or BRLT or SIG or MEDP or ICLR a better buy right now?

For growth investors, Medpace Holdings, Inc.

(MEDP) is the stronger pick with 20. 0% revenue growth year-over-year, versus -100. 0% for Signet Jewelers Limited (SIG). ICON Public Limited Company (ICLR) offers the better valuation at 13. 1x trailing P/E (10. 7x forward), making it the more compelling value choice. Analysts rate ICON Public Limited Company (ICLR) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ISPC or BRLT or SIG or MEDP or ICLR?

On trailing P/E, ICON Public Limited Company (ICLR) is the cheapest at 13.

1x versus Medpace Holdings, Inc. at 27. 7x. On forward P/E, Signet Jewelers Limited is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Medpace Holdings, Inc. wins at 0. 78x versus ICON Public Limited Company's 1. 53x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ISPC or BRLT or SIG or MEDP or ICLR?

Over the past 5 years, Medpace Holdings, Inc.

(MEDP) delivered a total return of +167. 0%, compared to -99. 9% for iSpecimen Inc. (ISPC). Over 10 years, the gap is even starker: MEDP returned +1426% versus ISPC's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ISPC or BRLT or SIG or MEDP or ICLR?

By beta (market sensitivity over 5 years), Brilliant Earth Group, Inc.

(BRLT) is the lower-risk stock at 1. 14β versus Signet Jewelers Limited's 1. 77β — meaning SIG is approximately 55% more volatile than BRLT relative to the S&P 500. On balance sheet safety, iSpecimen Inc. (ISPC) carries a lower debt/equity ratio of 9% versus 55% for Medpace Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ISPC or BRLT or SIG or MEDP or ICLR?

By revenue growth (latest reported year), Medpace Holdings, Inc.

(MEDP) is pulling ahead at 20. 0% versus -100. 0% for Signet Jewelers Limited (SIG). On earnings-per-share growth, the picture is similar: Signet Jewelers Limited grew EPS 100. 0% year-over-year, compared to -888. 6% for Brilliant Earth Group, Inc.. Over a 3-year CAGR, MEDP leads at 20. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ISPC or BRLT or SIG or MEDP or ICLR?

Medpace Holdings, Inc.

(MEDP) is the more profitable company, earning 17. 8% net margin versus -543. 7% for iSpecimen Inc. — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MEDP leads at 21. 1% versus -465. 4% for ISPC. At the gross margin level — before operating expenses — BRLT leads at 57. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ISPC or BRLT or SIG or MEDP or ICLR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Medpace Holdings, Inc. (MEDP) is the more undervalued stock at a PEG of 0. 78x versus ICON Public Limited Company's 1. 53x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Signet Jewelers Limited (SIG) trades at 9. 2x forward P/E versus 47. 7x for Brilliant Earth Group, Inc. — 38. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SIG: 26. 0% to $110. 00.

08

Which pays a better dividend — ISPC or BRLT or SIG or MEDP or ICLR?

In this comparison, BRLT (1.

8% yield) pays a dividend. ISPC, SIG, MEDP, ICLR do not pay a meaningful dividend and should not be held primarily for income.

09

Is ISPC or BRLT or SIG or MEDP or ICLR better for a retirement portfolio?

For long-horizon retirement investors, Medpace Holdings, Inc.

(MEDP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 21), +1426% 10Y return). Signet Jewelers Limited (SIG) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MEDP: +1426%, SIG: -9. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ISPC and BRLT and SIG and MEDP and ICLR?

These companies operate in different sectors (ISPC (Healthcare) and BRLT (Consumer Cyclical) and SIG (Consumer Cyclical) and MEDP (Healthcare) and ICLR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ISPC is a small-cap quality compounder stock; BRLT is a small-cap quality compounder stock; SIG is a small-cap quality compounder stock; MEDP is a mid-cap high-growth stock; ICLR is a small-cap deep-value stock. BRLT pays a dividend while ISPC, SIG, MEDP, ICLR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ISPC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

BRLT

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Stocks Like

SIG

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
Run This Screen
Stocks Like

MEDP

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 13%
  • Net Margin > 10%
Run This Screen
Stocks Like

ICLR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ISPC and BRLT and SIG and MEDP and ICLR on the metrics below

Revenue Growth>
%
(ISPC: -96.5% · BRLT: 6.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.